Statin-fibrate combinations in patients with combined hyperlipedemia.
about
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewDo we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentDifferential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action.
P2860
Statin-fibrate combinations in patients with combined hyperlipedemia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Statin-fibrate combinations in patients with combined hyperlipedemia.
@en
Statin-fibrate combinations in patients with combined hyperlipedemia.
@nl
type
label
Statin-fibrate combinations in patients with combined hyperlipedemia.
@en
Statin-fibrate combinations in patients with combined hyperlipedemia.
@nl
prefLabel
Statin-fibrate combinations in patients with combined hyperlipedemia.
@en
Statin-fibrate combinations in patients with combined hyperlipedemia.
@nl
P1433
P1476
Statin-fibrate combinations in patients with combined hyperlipedemia.
@en
P2093
Kontopoulos AG
Papageorgiou AA
P304
P356
10.1016/S0021-9150(00)00726-7
P577
2001-03-01T00:00:00Z